Impact of Neuropsychological Disorders in Multiple Sclerosis

Impact of Neuropsychological Disorders on Visual Exploration, Walking Initiation and Walking in Multiple Sclerosis

The study involves MS patients with and without neuropsychological disorders.

The patient will benefit from:

• A routine neuropsychological assessment, including a cognitive and emotional assessment
• A clinical examination
• A three-dimensional analysis of movement

Inclusion Criteria:

• Understanding and able to speak French
• Carriers of MS with relapsing remitting form (RRMS-RR) with an EDSS <4
• No significant motor, cerebellar or somesthesia disorders of the upper limbs or visual disturbances (side to a visual EDSS <2)
• Absence of corticosteroid intake in the last four weeks
• Benefiting from health insurance coverage
• Not showing any flare-ups or worsening of the disease in the last 6 weeks
• No botulinum toxin injection for more than 4 months

Exclusion Criteria:

• People with previous neurological pathologies, head trauma with loss of consciousness, psychiatric pathologies, serious general ailments, perceptual or dysarthric disorders preventing verbal communication or reading,
• Treatment with psychotropic drugs (except benzodiazepines and hypnotics).
• Refusal to participate after clear and fair information about the study.
• Adults under tutorship, curatorship or safeguard of justice
• With orthopedic treatment influencing walking
• Pregnant woman